AIBTRUST develops and provides a medical information distribution platform utilizing Web 3.0 technology. The company offers the secure patient-controlled medical information management application MediReco and the DX system Health Interview, which facilitates the ethical utilization of clinical information by generative AI. AIBTRUST aims to promote the secure distribution and utilization of medical data, thereby contributing to the advancement of medical AI.
[画像1: https://prtimes.jp/i/142041/10/resize/d142041-10-28412f8798171e552a95-4.png ] AIBTRUST株式会社（本社：大阪府大阪市北区、代表取締役：森岡 康一、以下「当社」）は、独立行政法人日本貿易振興機構...
AIBTRUST株式会社（本社：大阪府大阪市北区、代表取締役：森岡 康一）は、本日2026年7月1日に京都市下京区に開院した「京都はぎわらクリニック」（院長：萩原 英恵）に対し、自社が提供する医療機関向けフルDXプ...
[画像: https://prtimes.jp/i/142041/8/resize/d142041-8-84e96744afebe5adfee5-1.png ] 電子カルテ導入だけでは進まない医療DXの本質的解決策として、AIBTRUST株式会社（本社：大阪市北区）は2026年6月、医療機...
[画像: https://prtimes.jp/i/142041/7/resize/d142041-7-7821e35f894f3d7378a6-0.png ] AIBTRUST株式会社（本社：大阪市北区、代表取締役：森岡 康一、以下「当社」）は、東京都が支援する日本発メドテック・ス...
[画像1: https://prtimes.jp/i/142041/5/resize/d142041-5-d82741db971a5e5767a4-1.png ] AIBTRUST株式会社（以下「AIBTRUST」）（本社：東京都港区、代表取締役：森岡康一）は、法人向けWeb3.0（ブロックチェー...
AIBTRUST株式会社（以下「AIBTRUST」）（本社：東京都港区、代表取締役：森岡康一）は、大阪大学ベンチャーキャピタル株式会社（以下「OUVC」）（本社：大阪府吹田市、代表取締役社長：清水速水）を無限責任組合...
[画像1: https://prtimes.jp/i/142041/2/resize/d142041-2-9532af4b76b555811bc7-0.png ] AIBTRUST株式会社（本社：東京都港区、代表取締役社長：森岡康一）は、医療機関が患者様に安全に医療情報を返却する事...
QuEL, Inc. is a spinout startup from the University of Osaka developing qubit controllers; a crucial component in quantum computer hardware.
A startup expanding from AI development into GPU cloud and energy trading. By addressing high power consumption and integrating technologies, it leverages synergies across AI, infrastructure, and energy to build a sustainable foundation for the future.
We build and operate "OneICU," one of the world's largest databases, based on ICU data collected nationwide in Japan. As a data-sharing platform for healthcare institutions, we are expanding participating sites and returning integrated datasets to member hospitals to promote research and publications. For pharmaceutical and medical device companies, we collaborate with DeNA and JMDC to provide analytical support leveraging third-party databases as well. For hospitals, we offer AI solutions for ICU discharge/transfer coordination and for DPC coding support and clinical narrative drafting, helping improve operational efficiency.
Gold nanoparticles, which are smaller than the wavelength of light, are surrounded by a certain type of light called plasmons. This makes the gold nanoparticles act like an antenna or lens that collects and concentrates light. Using this property of concentrating photoelectric fields, we are developing dye-free analytical technology and a hidden barcode, in other word, tiny stealth tags for supply chain security.
